Your browser doesn't support javascript.
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Furer, Victoria; Rondaan, Christien; Agmon-Levin, Nancy; van Assen, Sander; Bijl, Marc; Kapetanovic, Meliha Crnkic; de Thurah, Annette; Mueller-Ladner, Ulf; Paran, Daphna; Schreiber, Karen; Warnatz, Klaus; Wulffraat, Nico M; Elkayam, Ori.
  • Furer V; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel furer.rheum@gmail.com.
  • Rondaan C; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Agmon-Levin N; Medical Microbiology and Infection Prevention, UMCG, Groningen, The Netherlands.
  • van Assen S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Bijl M; Clinical Immunology, Angioedema and Allergy Unit, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel.
  • Kapetanovic MC; Internal Medicine (Infectious Diseases), Treant Care Group, Hoogeveen, The Netherlands.
  • de Thurah A; Internal Medicine and Rheumatology, Martini Hospital, Groningen, The Netherlands.
  • Mueller-Ladner U; Department of Clinical Sciences, Lund, Section for Rheumatology, Lund University, Lund and Skåne University Hospital, Lund, Sweden.
  • Paran D; Rheumatology, Aarhus University Hospital, Århus N, Denmark.
  • Schreiber K; Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Warnatz K; Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University, Giessen, Germany.
  • Wulffraat NM; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Elkayam O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
RMD Open ; 7(1)2021 02.
Article in English | MEDLINE | ID: covidwho-1102204
ABSTRACT
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Rheumatic Diseases / COVID-19 Vaccines Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Aged / Humans / Middle aged / Young adult Language: English Year: 2021 Document Type: Article Affiliation country: Rmdopen-2021-001594

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Rheumatic Diseases / COVID-19 Vaccines Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Aged / Humans / Middle aged / Young adult Language: English Year: 2021 Document Type: Article Affiliation country: Rmdopen-2021-001594